Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society
Dis Esophagus
.
2022 Oct 14;35(10):doac056.
doi: 10.1093/dote/doac056.
Authors
Anju Murayama
1
2
,
Sae Kamamoto
1
3
,
Haruki Shigeta
1
2
,
Hiroaki Saito
1
4
,
Erika Yamashita
1
,
Tetsuya Tanimoto
1
5
,
Ozaki Akihiko
1
6
Affiliations
1
Medical Governance Research Institute, Minato-ku, Japan.
2
School of Medicine, Tohoku University, Sendai City, Japan.
3
School of Medicine, Hamamatsu University, Hamamatsu City, Japan.
4
Department of Internal Medicine, Soma Central Hospital, Soma City, Japan.
5
Department of Internal Medicine, Navitas Clinic Tachikawa, Tachikawa City, Japan.
6
Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki City, Japan.
PMID:
35980294
DOI:
10.1093/dote/doac056
No abstract available
Publication types
Letter
Comment
MeSH terms
Conflict of Interest*
Esophageal Neoplasms* / drug therapy
Humans
Japan
Pharmaceutical Preparations
Substances
Pharmaceutical Preparations